Skip to content

Minimally Invasive Locking Plate Fixation vs Reamed Intramedullary Nail Fixation on Patients With Open Tibia Fracture

A Prospective Randomized Trial Comparing the Effect of Minimally Invasive Locking Plate Fixation and Reamed Intramedullary Nail Fixation on Patients With Gustilo I-III A Open Tibia Fracture

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04072094
Enrollment
300
Registered
2019-08-28
Start date
2020-06-30
Completion date
2025-06-30
Last updated
2020-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Open tíbia Fracture

Brief summary

The best treatment for the open tibia fractures remains controversial. It is unknown whether minimally invasive locking plate or reamed intramedullary nail fixation will result in lower complication rates and better function.

Detailed description

The best fixation method for open tibial fractures remains controversial. The current standard treatment options recommended the use of intramedullary nail for treating such fractures. Recent studies also showed favorable results for the use of plates in managing open tibial fractures. However, it is unknown whether locking plate or intramedullary nail fixation will result in lower complication rates and better function. This study is a prospective, randomized trial to compare the safety and efficiency of minimally invasive plate osteosynthesis and reamed intramedullary nails in treating type I-II open tibial shaft fractures. The investigators hypothesize that neither intervention resulted in a superior disability rating at 12 months. Outcomes evaluated will include the rate of infection, the number of re-hospitalization for the complication, the time to bone healing, Patient-Reported outcome and quality of life and other complications.

Interventions

PROCEDUREMinimally Invasive Locking Plate Fixation

Patients randomized to the Minimally Invasive Locking Plate Fixation arm will be treated with plate fixation. The plate may be applied in a percutaneous fashion. Any combination of locked and/or non-locked screws may be used.

Patients randomized to the Intramedullary Nail Fixation arm will be receive a standard locked intramedullary nail fixation. The nail must use at least one static interlock proximal to and one static interlock distal to the fracture site. The nail may be placed with a reamed technique.

Sponsors

Taizhou Hospital
CollaboratorOTHER
Ningbo No.2 Hospital
CollaboratorOTHER
The First People's Hospital of Huzhou
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Ages 18 - 60 years inclusive * Open diaphyseal fracture * Gustilo-Anderson Type I, II, IIIA

Exclusion criteria

* Closed, periarticular or pathological fracture * Gustilo-Anderson Type IIIB,IIIC * Patients with concomitant fractures in the ipsilateral limb * The patient is unable to medically tolerate general anesthesia * The patient is unable to provide informed consent or comply with completing questionnaires * Tibia already infected as diagnosed by a surgeon * The patient has been diagnosed with a severe psychiatric condition

Design outcomes

Primary

MeasureTime frameDescription
LEFS12 monthsfailure.

Secondary

MeasureTime frameDescription
EQ-5D12 monthsReported Outcome and Quality of Life

Other

MeasureTime frameDescription
SF-1212 monthsReported Outcome and Quality of Life
Fracture Healing12 monthsFracture healing is measured by the treating surgeon using standard clinical criteria.
Complications12 monthsSoft tissue complications

Contacts

Primary ContactZhao-ming Ye, MD
2192002@zju.edu.cn+86-571-87783553
Backup ContactLing-ling Sun, MD
sunlingling@zju.edu.cn+86-571-87783553

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026